Vancouver, British Columbia — January 16, 2026 — Leads & Copy — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) announced a series of equity compensation and marketing initiatives to support its growth strategy and enhance market awareness.
Optimi has approved the grant of an aggregate of 850,000 stock options and 555,000 restricted share rights to certain directors, officers, employees, and key individuals associated with the company.
The options are exercisable for five years from the date of issuance at an exercise price of $0.50 per common share. The restricted share rights will vest and convert into common shares of the company for no additional consideration. Any common shares issued will be subject to a statutory hold period expiring four months and one day following the date of issuance.
The company has entered into a research sponsorship agreement with Diamond Equity Research LLC, an unregistered equity research firm headquartered in New York. DER will provide independent research coverage on the company, including the preparation of an initiation report outlining the investment opportunity and incorporating at least one financial valuation model.
Research coverage and related content are expected to be distributed through various financial and social media platforms, including FactSet, LinkedIn, Yahoo Finance, Google Finance, X (formerly Twitter), Zacks, and Thomson One.
Optimi has engaged Native Ads Inc. to provide investor awareness and promotional services, subject to approval by the Canadian Securities Exchange. The digital media and content distribution campaign is expected to commence in the first quarter of 2026 and continue for up to 24 months, or until the approved budget is fully expended.
Native Ads will conduct a digital advertising campaign to increase awareness and understanding of the company and its regulated pharmaceutical product portfolio, including its MDMA and psilocybin drug products. The campaign will include advertising across search engines, financial publications, and financial websites. The company has approved a budget of up to US$350,000 for these services.
Native Ads will not receive any securities of the company as compensation, and the agreement does not include any performance based compensation factors. Native Ads and Optimi are arm’s length parties, and neither Native Ads nor its principals hold any direct or indirect interest in the securities of the company as of the date of the agreement.
Dane Stevens, CEO
Optimi Health Corp.
Telephone: (778) 7614551
Email: investors@optimihealth.ca
Source: Optimi Health Corp.
